We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BETRF market cap is 9.79M. The company's latest EPS is CAD -0.0223 and P/E is -3.59.
| Year End January 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.47M | -16.64M | -8.05M | -4.83M | -3.21M |
| Net Income | -19.59M | -36.35M | -12.16M | -9.02M | -2.89M |
| Year End January 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 8.25M | 1.37M | 1.16M | 75k | 325k |
| Total Liabilities | 5.59M | 5.98M | 5.04M | 7.61M | 8.02M |
| Total Equity | 2.66M | -4.61M | -3.88M | -7.53M | -7.7M |
| Year End January 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -7.88M | -7.16M | -11.2M | -1.5M | -2.47M |
| Investing | -1.14M | -71k | N/A | N/A | N/A |
| Financing | 12.23M | 4.09M | 11.23M | 1.34M | 2.5M |
| Market Cap | 9.79M |
| Price to Earnings Ratio | -3.59 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 266.67 |
| Price to Book Ratio | -1.35 |
| Dividend Yield | - |
| Shares Outstanding | 129.46M |
| Average Volume (1 week) | 41.51k |
| Average Volume (1 Month) | 25.48k |
| 52 Week Change | 30.12% |
| 52 Week High | 0.15 |
| 52 Week Low | 0.0546 |
| Spread (Intraday) | 0.05 (66.01%) |
| Company Name | BetterLife Pharma Inc (QB) |
| Address |
1275 west 6th avenue #300 vancouver, british columbia V6H 1A6 |
| Website | https://www.abetterlifepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
